Riskpilot← Back to searchSign inGet full accessHässleholms tandläkargrupp AB
ABDissolvedOrg 5569849804Dental practice care activities · NACE 8623Est. 20140 employees
Revenue 2025
SEK 6M
-2% vs 2024
EBITDA margin
5.1%
-40% vs 2024
Equity ratio
39.9%
Financial strength
Net profit 2025
SEK 85K
-66% vs 2024
| Revenue | SEK 6M | -2% |
| EBITDA | SEK 303K | -40% |
| Net profit | SEK 85K | -66% |
| Total assets | SEK 1,7M | -8% |
| Equity | SEK 681K | -2% |
| Employees | 0 | — |
Legal name
Hässleholms tandläkargrupp AB
Org number
5569849804
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
2 oktober 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva tandläkarverksamhet.
Address
Email
christopher.ostberg@smile.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 978 | 5 235 | 5 707 | 6 091 | 5 972 |
| Staff expenses | — | — | — | −3 488 | −3 310 |
| EBITDA | 668 | 379 | 374 | 508 | 303 |
| Depreciation & amort. | −176 | −181 | −165 | −134 | −145 |
| EBIT | 492 | 198 | 209 | 374 | 157 |
| Net financials | −58 | −52 | −59 | −52 | −38 |
| Profit before tax | 434 | 146 | 149 | 323 | 119 |
| Tax | −98 | −35 | −37 | −72 | −35 |
| Net profit | 336 | 111 | 112 | 251 | 85 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 047 | 1 752 | 1 592 | 1 848 | 1 707 |
| Equity | 473 | 334 | 446 | 697 | 681 |
| Long-term debt | 933 | 773 | 613 | 467 | 293 |
| Short-term debt | 641 | 645 | 533 | 685 | 733 |
| Total debt | 1 574 | 1 418 | 1 146 | 1 152 | 1 026 |
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
20212025
Equity ratio
39.9%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
12.4%
This company
18.4%
Market median
+33% vs market
20212025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20212025
Asset turnover
3.50×
This company
1.12×
Market median
+212% vs market
20212025
Debt / equity
1.51×
This company
0.62×
Market median
-144% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MB Chief Executive Officer | Chief Executive Officer | 2025 |
AG Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
ME | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Board of Directors | 2020 – 2025 | |
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hässleholms tandläkargrupp AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Markus Emanuel Ahlberg | Audit | 0 companies |
| Malin Birgitta Schmidt | Chief Executive Officer | 0 companies |
| Anna Gabriella Hermansson | Chief Auditor | 0 companies |
| Anna Cecilia Christina Dahlgren | Board of Directors | 0 companies |
| Christopher Sebastian Östberg | Deputy Board Member | 0 companies |
| Anton Nils Ola Dahlgren | Deputy Board Member | 0 companies |